EcoR1 Capital LLC 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:47 pm Sale |
2024-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 3,341,653 4.000% |
-2,100,243 (-38.59%) |
Filing |
| 2024-11-15 10:34 am Sale |
2024-09-30 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 5,441,896 6.400% |
-1,553,965 (-22.21%) |
Filing |
| 2024-02-15 11:35 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
0 (Unchanged) |
Filing |
| 2024-02-15 09:15 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
0 (Unchanged) |
Filing |
| 2024-02-14 8:02 pm Purchase |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
811,000 (+13.11%) |
Filing |
| 2023-02-10 1:37 pm Purchase |
2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,184,861 7.400% |
808,727 (+15.04%) |
Filing |
| 2021-12-10 5:08 pm Purchase |
2021-12-01 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 5,376,134 6.500% |
5,376,134 (New Position) |
Filing |